Philippe Lesnik

7.9k total citations · 3 hit papers
89 papers, 5.9k citations indexed

About

Philippe Lesnik is a scholar working on Surgery, Immunology and Molecular Biology. According to data from OpenAlex, Philippe Lesnik has authored 89 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 29 papers in Immunology and 19 papers in Molecular Biology. Recurrent topics in Philippe Lesnik's work include Atherosclerosis and Cardiovascular Diseases (16 papers), Lipoproteins and Cardiovascular Health (14 papers) and Phagocytosis and Immune Regulation (11 papers). Philippe Lesnik is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (16 papers), Lipoproteins and Cardiovascular Health (14 papers) and Phagocytosis and Immune Regulation (11 papers). Philippe Lesnik collaborates with scholars based in France, United States and Australia. Philippe Lesnik's co-authors include M. John Chapman, Israel Charo, Christopher A. Haskell, Edward A. Fisher, Olivier Descamps, L. Masana, Kausik K. Ray, Henry N. Ginsberg, Pierre Amarenco and Marja‐Riitta Taskinen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Philippe Lesnik

87 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lipoprotein(a) as a cardiovascular risk factor: current status

2010 1.3k citations M. John Chapman, Philippe Lesnik et al. profile →
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

2011 887 citations M. John Chapman, Philippe Lesnik et al. profile →
Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis

2020 256 citations Sophie Tran, Lucie Poupel et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Lesnik France	34	2.6k	1.6k	1.5k	1.1k	1.1k	89	5.9k
Brian J. Van Lenten United States	42	2.7k 1.0×	2.0k 1.3×	1.5k 1.0×	865 0.8×	1.6k 1.5×	57	6.9k
Marit Westerterp Netherlands	40	1.8k 0.7×	774 0.5×	1.7k 1.1×	641 0.6×	1.9k 1.7×	77	5.1k
Uwe J.F. Tietge Netherlands	49	3.0k 1.2×	2.1k 1.3×	935 0.6×	1.1k 1.0×	2.4k 2.2×	187	7.5k
Megan L. Wolfe United States	31	1.9k 0.7×	1.7k 1.1×	561 0.4×	1.3k 1.2×	785 0.7×	53	4.8k
Jian‐Jun Li China	40	2.5k 0.9×	887 0.6×	569 0.4×	1.2k 1.1×	834 0.8×	229	5.5k
Marcelo Amar United States	44	2.8k 1.1×	1.4k 0.9×	591 0.4×	704 0.6×	1.9k 1.7×	85	5.2k
Naohiko Sakai Japan	37	2.2k 0.9×	1.8k 1.1×	472 0.3×	1.1k 1.0×	1.2k 1.1×	90	4.8k
Jaye Chin‐Dusting Australia	43	1.2k 0.5×	1.0k 0.7×	962 0.6×	1.5k 1.3×	1.3k 1.2×	129	5.5k
Fernando Civeira Spain	43	4.9k 1.9×	2.4k 1.6×	686 0.5×	1.9k 1.7×	1.4k 1.2×	286	8.0k
Wilfried Le Goff France	34	2.2k 0.9×	1.4k 0.9×	563 0.4×	567 0.5×	1.2k 1.1×	110	4.1k

Countries citing papers authored by Philippe Lesnik

Since Specialization

Citations

This map shows the geographic impact of Philippe Lesnik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Lesnik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Lesnik more than expected).

Fields of papers citing papers by Philippe Lesnik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Lesnik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Lesnik. The network helps show where Philippe Lesnik may publish in the future.

Co-authorship network of co-authors of Philippe Lesnik

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Lesnik. A scholar is included among the top collaborators of Philippe Lesnik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Lesnik. Philippe Lesnik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hua, Marie Lhomme, Sophie Galier, et al.. (2025). MAIT Cells Promote Cholesterol Excretion Pathways Mitigating Atherosclerosis. Circulation Research. 136(9). 968–981.

Carreau, Valérie, Maryse Guérin, Éric Frisdal, et al.. (2023). Transcriptomic profile helps to identify high-risk heterozygous familial hypercholesterolemia patients. Archives of cardiovascular diseases. 117(1). S107–S108. 1 indexed citations

Devel, Laurent, Robert Thaï, Lucie Poupel, et al.. (2023). Targeted delivery of LXR-agonists to atherosclerotic lesions mediated by polydiacetylene micelles. Nanoscale. 15(46). 18864–18870. 4 indexed citations

Toubal, Amine, Badr Kiaf, Lucie Beaudoin, et al.. (2020). Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity. Nature Communications. 11(1). 3755–3755. 120 indexed citations

Tran, Sophie, Lucie Poupel, Sébastien Dussaud, et al.. (2020). Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis. Immunity. 53(3). 627–640.e5. 256 indexed citations breakdown →

Galle-Treger, Lauriane, Martine Moreau, Raphaëlle Ballaire, et al.. (2019). Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis. Cardiovascular Research. 116(3). 554–565. 21 indexed citations

Bonnefont‐Rousselot, Dominique, Randa Bittar, Pierre Demondion, et al.. (2019). Antiatherogenic properties of high-density lipoproteins from arterial plasma are attenuated as compared to their counterparts of venous origin. Nutrition Metabolism and Cardiovascular Diseases. 30(1). 33–39. 5 indexed citations

Roy, Tiphaine Le, Emelyne Lécuyer, Benoît Chassaing, et al.. (2019). The intestinal microbiota regulates host cholesterol homeostasis. BMC Biology. 17(1). 94–94. 148 indexed citations

Béliard, Sophie, Wilfried Le Goff, Flora Saint-Charles, et al.. (2017). Modulation of Gr1low monocyte subset impacts insulin sensitivity and weight gain upon high-fat diet in female mice. International Journal of Obesity. 41(12). 1805–1814. 6 indexed citations

10.

Perségol, L., Maryam Darabi, Marie Lhomme, et al.. (2017). Small dense HDLs display potent vasorelaxing activity, reflecting their elevated content of sphingosine-1-phosphate. Journal of Lipid Research. 59(1). 25–34. 25 indexed citations

11.

Lesnik, Philippe, et al.. (2017). Peak inspiratory flow as predictor for tracheotomy. European Annals of Otorhinolaryngology Head and Neck Diseases. 135(1). 3–6. 7 indexed citations

12.

Frederiksen, S., Peter Karlskov‐Mortensen, Sameer D. Pant, et al.. (2017). Haplotypes on pig chromosome 3 distinguish metabolically healthy from unhealthy obese individuals. PLoS ONE. 12(6). e0178828–e0178828. 5 indexed citations

13.

Gérard, Philippe, et al.. (2016). Recent Patents on Hypocholesterolemic Therapeutic Strategies: An Update. PubMed. 9(1). 36–44. 2 indexed citations

14.

Rached, Fabiana Hanna, Marie Lhomme, Laurent Camont, et al.. (2015). Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: Relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851(9). 1254–1261. 46 indexed citations

15.

Frisdal, Éric, Philippe Lesnik, Paul Robillard, et al.. (2011). Interleukin-6 Protects Human Macrophages from Cellular Cholesterol Accumulation and Attenuates the Proinflammatory Response. Journal of Biological Chemistry. 286(35). 30926–30936. 91 indexed citations

16.

Moreau, Martine, Flora Saint-Charles, Francesco Potì, et al.. (2011). Cholesteryl Ester Transfer Protein Expression Partially Attenuates the Adverse Effects of SR-BI Receptor Deficiency on Cholesterol Metabolism and Atherosclerosis. Journal of Biological Chemistry. 286(19). 17227–17238. 39 indexed citations

17.

Pierre, Sandrine V., Philippe Lesnik, Laurent Bonello, et al.. (2008). The standardized Ginkgo biloba extract Egb-761 protects vascular endothelium exposed to oxidized low density lipoproteins.. PubMed. 54 Suppl. OL1032–42. 15 indexed citations

18.

Gautier, Emmanuel L., Thierry Huby, Flora Saint-Charles, et al.. (2008). Enhanced Dendritic Cell Survival Attenuates Lipopolysaccharide-Induced Immunosuppression and Increases Resistance to Lethal Endotoxic Shock. The Journal of Immunology. 180(10). 6941–6946. 62 indexed citations

19.

Huby, Thierry, Chantal Doucet, C. Dachet, et al.. (2006). Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues. Journal of Clinical Investigation. 116(10). 2767–2776. 97 indexed citations

20.

Petit, Laure, Philippe Lesnik, Christiane Dachet, et al.. (1999). The Promoter of Human Tissue Factor Pathway Inhibitor Gene. Thrombosis Research. 95(5). 255–262. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact